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Background: In the setting of liver injury hepatic progenitor cells are activated, counterbalancing the inhibited
regenerative capacity of mature hepatocytes. Chronic activation of this compartment may give rise to a subset of
liver tumours with poor prognosis. SerpinB3, a serpin over-expressed in injured liver and in primary liver cancer, has
been shown to induce apoptosis resistance, epithelial to mesenchymal transition and to increase TGF-beta and Myc
expression. Aim of the present study was to explore the presence of SerpinB3 in hepatic progenitor cells in human
livers and in a mouse model of liver stem/progenitor cell activation.
Hepatic progenitor cells were analysed in foetal and adult livers at protein and transcriptional levels. To induce
experimental activation of the liver stem/progenitor compartment, C57BL/6J mice were injected with
lipopolysaccharide plus D-galactosamine and were sacrificed at different time points. Liver cDNA was amplified
using specific primers for mouse-homologous SerpinB3 isoforms and automatically sequenced.
Results: The presence of SerpinB3 in the progenitor cell compartment was detected in sorted human foetal and
adult epithelial cell adhesion molecule (EpCAM) positive liver cells. By immunohistochemistry SerpinB3 was found in
human cirrhotic livers in portal areas with progenitor cell activation showing ductular proliferation. CK-7, CK-19,
EpCAM and CD-90 positive cell were also positive for SerpinB3. In the animal model, time course analysis in liver
specimens revealed a progressive increase of SerpinB3 and a parallel decrease of activated caspase 3, which was
barely detectable at 20 hours. Transcription analysis confirmed the presence of SerpinB3-homologous only in the
liver of injured mice and sequence analysis proved its belonging to mouse Serpinb3b.
Conclusion: SerpinB3 is highly expressed in hepatic stem/progenitor cell compartment of both foetal and adult livers.
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The liver is characterized by a unique and remarkable cap-
acity to regenerate upon various injuries, such as partial
hepatectomy or toxic insults. Liver regeneration can usu-
ally be achieved by proliferation of the differentiated hepa-
tocytes, without involvement of the stem/progenitor cell
compartment. However, under severe and/or chronic liver
damage conditions in which the proliferative capacity of
normal adult hepatocytes is inhibited, the stem/progenitor
cells contribute to the regeneration process [1]. This com-
partment, defined in rodents “oval cell compartment”, is
composed by quiescent cells that originate from niches lo-
cated in the canals of Hering and in normal bile ducts* Correspondence: patrizia@unipd.it
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reproduction in any medium, provided the or[2,3]. Oxidative stress conditions can induce activation of
liver progenitor cells, known as ductular reaction in hu-
man livers, characterized by the expansion of the small bil-
iary cells compartment, which can differentiate into biliary
epithelial cells and hepatocytes [4]. The occurrence of pro-
genitor cell proliferation in humans has been described in
the late stages of cirrhosis and can give rise to a peculiar
subset of primary liver tumors with poor prognosis [5].
SerpinB3 (SB3) is a member of the ovalbumin-serin prote-
ase inhibitor family (ov-serpins) [6] and within the normal
liver its expression was seen in portal interlobular ducts,
in the walls of hepatic arteries and sometimes in the endo-
thelial cells of the portal vein, but not in normal adult he-
patocytes, except some focal faint positivity of hepatocytes
in the limiting plate [7]. However, chronically damaged he-
patocytes express this serpin [8] and the highest levels are
achieved in preneoplastic and neoplastic liver lesionsLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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plastic cells from apoptotic death induced by several kinds
of stimuli [12] and the suggested molecular target location
has been supposed upstream caspase 3 [13]. Recent data
have revealed that SB3 increases the synthesis of Myc
oncogene [7] and of transforming growth factor-beta
(TGF-β) [8]. In addition, this serpin has been found to in-
duce epithelial-to-mesenchymal transition, associated with
β-catenin accumulation, increased cellular proliferation
and invasiveness [14]. The squamous cell carcinoma anti-
gen locus, which in humans encodes the nearly identi-
cal serpins SerpinB3 (SCCA1) and SerpinB4 (SCCA2)
[15], in mouse encodes four full-length genes, Ser-
pinb3a, -b3b, -b3c, and -b3d, indicating their relation
to an ancestral serpin common to both sets of mam-
malian genes. This notion is supported by the phylo-
genetic relationship ascertained between the predicted
amino acid sequences of the existing SCCA-related genes
of human (SerpinB3 and -B4), mouse (Serpinb3a, -3b, -3c,
and -3d) and rat (Serpinb3a and -3b) genome [16].
SB3 expression has not been studied so far in hepatic
stem/progenitor cells and the effect of its possible pres-
ence in this compartment has not been investigated yet.
In this study we have explored the expression of SB3
in human hepatic stem/progenitor cells and in a mouse
model of stem/progenitor cells induction, determined by
the administration of lipopolysaccharide (LPS) and D-
galactosamine (D-GalN) [17].
Methods
Immunohistochemistry in human liver cirrhosis
Liver specimens obtained from sequential liver sections of
four patients with HCV-related cirrhosis (METAVIR F4)
were immunostained for SB3, for cytokeratin 7 (CK7),
cytokeratin 19 (CK19), thymocyte antigen 1 (Thy1 or
CD90), tyrosine-protein kinase Kit (c-kit or CD117), trans-
membrane sialomucin protein (CD34) and epithelial cell
adhesion molecule (EpCAM). The use of human liver
bioptic material, obtained after written consent, conforms
to the ethical guidelines of the 1975 Declaration of
Helsinki and was approved by the Ethical Committee of
the University of Torino. Immunohistochemistry was per-
formed on sequential paraffin liver sections (2 micron
thick) that were incubated with specific monoclonal anti-
bodies (final dilutions 1:50) raised against SB3 (Santa Cruz
Biothecnology Inc, Santa Cruz, CA, USA), CK-7 and CK-
19 (Dako, Glostrup, Denmark), EpCAM (Miltenyi Biotec
GmbH, Bergisch Gladbach, Germany), CD90, CD117
and CD34 (clones G7, 2B8 and MEC14.7, respectively;
BioLegent, London, UK), used as liver progenitor cells
markers [18-22]. Briefly, after microwave antigen retrieval,
primary antibodies were labeled using EnVision, HRPla-
belled System (Dako) antibodies directed against mouse
antigens and visualized by 3’- diaminobenzidine substrate.Negative controls were performed by replacing the re-
spective primary antibodies by isotype and concentrations
matched irrelevant antibody [23].
Human liver stem/progenitor cell isolation
Foetal livers (N = 4, weight 14–16 g) of 18 week gesta-
tional age were obtained by elective (trisomy 21) termin-
ation of pregnancy from the Department of Gynecology
(Sapienza, University of Rome, Italy). Non tumoral adult
liver specimens (3 different specimens) were obtained at
the time of liver surgery for primary liver cancer in a pa-
tient with non-alcoholic steatohepatitis (NASH) from the
Department of General Surgery and Organ Transplant-
ation, University of Rome “La Sapienza”. The protocols for
the use of foetal liver, obtained after written consent by
elective (trisomy 21) termination of pregnancy and for
adult liver, were approved by the Ethical Committee of
Sapienza, University of Rome, Italy.
Human stem/progenitor cells were isolated according to
Schmelzer E et al. [24,25]. Briefly, the liver was initially re-
duced in small fragments with lancets and then submitted
to enzymatic digestion (30 min at 37°C) in a cell buffer con-
taining 300 U/ml type I Collagenase (Sigma-Aldrich) and
0.3 mg/ml deoxyribonuclease (DNAse, Sigma-Aldrich).
This resulted in a homogeneous cell suspension that was
passed through pre-separation filters of 100 μ and enrich-
ment for stem/progenitor cells was performed by magnetic
immunoselection for epithelial cell adhesion molecule
(EpCAM). For this purpose, magnetic microspheres conju-
gated with anti-EpCAM monoclonal antibody (Miltenyi
Biotec GmbH, Bergisch Gladbach, Germany) were used.
From the initial cell suspension (pre-sorting = 1.30×108 cells),
1.5x107 EpCAM+ viable sorted cells were obtained. Isolated
cells were submitted to flow Cytometric (FC) analyses as de-
scribed [24,25]. Briefly, isolated cells were labeled with fluor-
escent primary antibodies (EpCAM-FITC, Miltenyi Biotec
Inc., Bergisch Gladbach, Germany; NCAM-PE (neural cell
adhesion molecule), R&D Systems Inc., Minneapolis, MN
USA) or adequate isotype controls. Cells were analyzed by a
FACScanto Flow Cytometer (Becton Dickson, Milan, Italy).
Ten thousand events were acquired and analyzed by Cell-
Diva software. Total RNA was extracted using the TRI
REAGENTTM (Sigma-Aldrich, St. Louis, MO, USA), fol-
lowing the manufacturer’s instructions [26]. The isolated
RNA was dissolved in 55 μL of RNase-free water and used
for molecular analysis.
Molecular techniques
Real time polymerase chain reaction in human liver
cell preparations
Total RNA (up to 1 μg) from human liver cell prepara-
tions was reverse transcribed using Superscript II re-
verse transcriptase (Invitrogen, Carlsbad, CA, USA) and
mRNA amplification for human SB3 was performed as
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sense SB3, 5′-GCAAATGCTCCAGAAGAAAG-3′; reverse
SB3, 5′-CGAGGCAAAATGAAAAGATG-3′. The house-
keeping gene Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (sense: 5′-TGGTAT TCGGGAAGGACTCAT
GAC-3′, reverse: 5′-ATGCCAGTGAGCTTCCCGTTCAG
C-3′) was determined in parallel in all the amplification sets
to assess the integrity of total RNA extracts.Reverse-transcription polymerase chain reaction and cDNA
sequencing in mouse livers
Polymerase chain reaction (PCR) analysis for SB3 was per-
formed on total RNA extracted from frozen mouse liver
samples. Total RNA (2.0 μg/sample) was used as a tem-
plate to create complementary DNA [27] and quantified by
spectrophotometry at 260 nm. To characterize the mouse-
homologous serpin isoforms, the following set of con-
served primers was used: sense: 5′- TTTTACACAAG
TCCTTTGTGGAGG-3′, antisense: 5′-CTGGACACATG-
GAAGAGACACCAC-3′, which allows the amplification
of the mouse Serpinb3a, -b3b and -b3c, homologous to hu-
man SerpinB3 and SerpinB4 [16,28]. The mRNA amplifica-
tion reaction was performed as described previously [27].
The amplified product was then transcribed to cDNA and
sequenced by direct sequencing, using an ABI 310 auto-
mated DNA sequencer (Apply Biosystems, Foster City,
CA, USA), according to manufacturer instructions. All the
obtained DNA sequencing data were already present in
GenBank and their accession numbers were reported in
the results section.
Homology search analysis to achieve maximal levels of
identity of sequenced nucleotides was carried out by Basic
Local Alignment Search Tool algorithm (BLAST), de-
signed to explore all of the available mouse transcript se-
quence databases [29]. To determine the relatedness of
the serpins from human and mouse, the deduced amino
acid sequences were examined using the ClustalX multiple
sequence alignment algorithm.
Western blot analysis
The protein expression of mouse SB3, cleaved caspase 3,
proliferative cell nuclear antigen (PCNA) and β-actin
was assessed by Western blot analysis using cellular ex-
tracts of liver tissue, as described previously [27].
The expression of each protein was detected using
the following primary antibodies: polyclonal anti-SB3
(Hepa-Ab, 1:462, kind gift of Dr. Fassina, Xeptagen,
Venice, Italy), polyclonal anti-cleaved caspase 3 (1:1000,
Cell Signaling Technology, Danvers, MA, USA), mono-
clonal anti-PCNA (1:100, Dako, Glostrup, Denmark),
monoclonal anti-β actin (1:1000, Sigma-Aldrich). Anti-
mouse IgG (1:1000, Amersham Bioscience, Arlington
Height, IL, USA) and anti-rabbit IgG (1:2000, Sigma-Aldrich) were used as horseradish peroxidase conju-
gated secondary antibodies.
Acute liver failure model
The study was carried out in adult C57BL/6J mice (Charles
River Italia S.p.A, Calco, Lecco), aged 12–14 weeks with a
weight range of 20–25 g, bred at the Animal Care Facility
of the Experimental Surgery Division of the University of
Padua.
To induce acute liver failure male C57BL/6J mice re-
ceived in preliminary experiments increasing concentra-
tions (3,3 -20 μg/Kg) of E. Coli lipopolysaccharide
(LPS, Sigma-Aldrich, St. Louis, MO) plus 700 mg/Kg of
D-galactosamine (D-GalN, Sigma-Aldrich) in PBS (1×) by
intraperitoneal injection [30] and were sacrificed at differ-
ent time points to assess the dose-dependent liver injury.
An additional group of 10 mice was inoculated with
5 μg/Kg of E. Coli LPS plus 700 mg/Kg of D-GalN, defined
as the optimal dose to achieve 24 hours mortality. Within
this group, a subgroup of 5 mice was sacrificed 5 hours
after injection, while the remaining mice were sacrificed
after 20 hours, by lethal dose of tiletamine hydrochloride.
As control, a similar group of mice was inoculated with
200 μl of PBS (1×). Liver specimens were cut in two parts,
one part was fixed with 4% paraformaldehyde in PBS,
followed by paraffin embedding, while the other part was
immediately frozen in liquid nitrogen and stored at −80°C
for further analysis.
The experimental protocol was approved by the Ani-
mal Investigation Committee of the Italian Ministry of
Health. All measures were taken to minimize any pain
or discomfort for the animals.
Statistical analysis
Statistical analysis was carried out using the Student’s t-test,
the non parametric Mann–Whitney test and Wilcoxon
matched pairs test, when appropriate; all tests were two-
tailed. The significance was set as p < 0.05. All analyses were
performed using GraphPad InStat software (San Diego,
CA, USA).
Results
SerpinB3 in human liver progenitor cells
Immunohistochemistry was carried out in serial sections
of human livers with HCV-related cirrhosis in order to
evaluate the expression of SB3 in human progenitor cell
compartment, typically found in portal tracts of cirrhotic
livers as ductular reaction of CK-7 and CK-19 positive
cells [4]. As shown in Figure 1A, staining of SB3 in con-
secutive liver sections clearly showed large numbers of
CK-7 and CK-19 positive cells that also expressed SB3.
In addition, similar areas positive for SB3 were also posi-
tive for EpCAM and CD-90, but negative for CD34 and
for CD117 (Figure 1B), supporting the hypothesis that
Figure 1 Immunohistochemistry in human liver cirrhosis. Immunohistochemistry on serial liver sections obtained from a cirrhotic patient with
ductular proliferation. A) Representative images show negative control (C-) and immunostaining for cytokeratin 7 (CK-7), cytokeratin 19 (CK-19) and for
SerpinB3. B) Serial liver sections immunostained for SerpinB3, EpCAM, CD-90, CD-34 and CD-117. Original magnification as indicated.
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partment [18-22].
Stem/progenitor cells from foetal or adult livers were
sorted for EpCAM by using magnetic beads. By flow cy-
tometry analysis, after sorting for EpCAM, 79.0 ± 15.4% of
freshly isolated cells were EpCAM positive for adult liver
and 92 ± 5.2% for foetal liver (Figure 2A).
In keeping with immunohistochemistry, mRNA of SB3
was detectable in stem/progenitor cells sorted as EpCAM
positive from human foetal and adult livers (Figure 2B).
Animal model
C57BL/6J mice, treated with increasing concentrations of
LPS (range: 3.3-20 μg/Kg) plus D-GalN displayed signs of
acute liver failure with progressive changes of hepaticFigure 2 Stem/progenitor cells analysis. A: Flow cytometry analysis of s
isolated by magnetic immunoselection for EpCAM. Flow cytometry analysis
demonstrated the enrichment of EpCAM + cells. A significant number of Ep
in human liver stem/progenitor cells. In the real time amplification for hum
the y-axis represents the relative mean mRNA level of the SB3 gene expres
lower panel agarose gel electrophoresis of individual corresponding samplarchitecture and liver cell necrosis. The dose of 5 μg/Kg of
LPS was defined as the optimal dose to carry on the exper-
iments over a time frame of 5–20 hours.Western blot analysis
Western blot analysis of total liver lysates from control and
LPS (5 μg/Kg)-DGalN injured mice was carried out at
5 hours and 20 hours after treatment. Densitometric exam-
ination showed that Serpinb3 protein became detectable
5 hours after liver injury, with a progressive increase over
time. After 20 hours, the highest expression of Serpinb3
was associated with a marked decrease of the active form
of caspase 3, supporting the parallel inhibition of apoptotic
activity, while PCNA levels remained unchanged (Figure 3).tem/progenitor cells isolated from foetal or adult livers. Cells were
, where cells were stained with anti-EpCAM and anti-NCAM antibodies,
CAM + cells were also positive for NCAM. B: RNA analysis for SerpinB3
an SerpinB3 data were normalized to GAPDH housekeeping gene and
sed by 2-ΔCt *10-5, with the bars representing the standard error. In the
es is shown as example.
Figure 3 Western blot analysis. Upper Panel) Representative images of Western blot analysis for Serpinb3, activated Caspase 3 and PCNA
in liver homogenates of two mice sacrificed at 5 hours (lanes 1,2) and of two mice sacrificed at 20 hours (lanes 3,4) after treatment with
LPS/D-galactosamine. The liver of a control mouse has also been shown. Lower Panel) Densitometric analysis of the above results expressed as
optical density (OD) of each molecule. The quantitative densitometric values are normalized to β-actin.
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To analyze the transcriptional products of the mouse SB3
isoforms, RT-PCR was carried out using primers for the
conserved regions of the genomic isoforms already de-
scribed in mouse [16,28]. In the liver of all treated mice, a
single band at the expected size for mouse SB3 mRNA,
corresponding to 214 bp, was detectable, while it was
absent in controls. Direct sequencing of the amplified
product was carried out and nucleotide sequence
alignment proved its belonging to mouse Serpinb3b
(GenBank accession number: NM_198680) (Figure 4),
which has the highest sequence homology with human
SerpinB3 (NM_006919). Furthermore, sequence homology
analysis of Serpinb3b showed a 94% identity with Serpinb3a
(NM_009126) and 88% with Serpinb3c (NM_201363).
Discussion
Chronic human liver diseases are characterized by continu-
ous liver damage and hepatocyte loss, with subsequent acti-
vation of the progenitor cell compartment [20]. Despite the
capacity of the adult human and rodent liver to reply to loss
of its cellular mass, it is widely acknowledged that impair-
ment of the regenerative capacity of hepatocytes may result
in proliferation and migration of cells forming ductular
structures, initially close to the biliary tree. The capacity of
these ductular structures to proliferate and differentiate intohepatocytes, in association with impaired liver regeneration,
has led to the conclusion that they may represent progeny
of facultative liver stem cells [31,32]. In recent years, con-
siderable interest has been devoted to the hepatic progeni-
tor cells, as tumors showing hepatic progenitor cell features
have a worse prognosis and a higher recurrence rate com-
pared to tumors lacking these characteristics [5,21].
The present study has provided evidence that in the
human progenitor cell compartment SB3 is detectable
in the same ductular structures that express stem/pro-
genitor cell markers, with multiple differentiating cap-
abilities [18,19,33]. Within the ductular reaction areas, a
high proportion of CK-7 and CK-19 positive cells pre-
sented indeed a positive staining for SB3. This SB3 posi-
tive cell population was also positive for EpCAM and
CD90, markers of mesenchymal and foetal liver stem cells.
This is the first report, at the best of our knowledge, indi-
cating that SB3 is present in human stem/progenitor cells
of hepatic origin. The lack of the hematopoietic markers
CD34 and CD117 in the same areas may exclude that this
population derives from circulating hematopoietic cells,
rather supporting its belonging to a distinct liver stem
cell-like population [34,35].
In addition, to evaluate the expression of SB3 in the
liver stem/progenitor cell compartment, EpCAM+ cells
were isolated by immunomagnetic sorting from foetal
Figure 4 Sequence analysis of Serpinb3b cDNA. Sequence analysis of Serpinb3b cDNA confirmed the presence of SerpinB3-homologous only
in the liver of injured mice, being not detectable in controls. Homology search analysis proved its belonging to mouse Serpinb3b.
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with the role of EpCAM+ cells as hepatic resident stem/
progenitor cells [36,37]. Moreover, microarray expres-
sion data from a panel of human tissue generated using
GNF Expression Atlas 2 Data from U133A chip (publicy
available through the UCSC Genome Browser website
http://genome.ucsc.edu/), further confirms that EpCAM
mRNA is robustly expressed in foetal liver. The detection
of SB3 RNA in the EpCAM+ cell fractions of human
foetal and adult livers supports strongly the presence of
this serpin in hepatic progenitor cells [22].
An animal model of stem/progenitor cell induction
after acute liver injury determined by LPS/D-GalN [38]
has also been studied. In this model hepatic injury is me-
diated by macrophages [39] and proinflammatory cyto-
kines, including IL-1, IL-6, IL-12 and TNF-α [40] lead to
hepatocyte necrosis and to massive hepatocyte apoptosis
[41]. Members of the TNF family are the best character-
ized stimuli for stem/progenitor cell proliferation, an
event that shares an unusual reciprocal relationship with
the proliferation of hepatocytes [42]. In our experimental
conditions, using total cell lysates, a progressive increase
of mouse SB3 and a parallel decrease of activated
caspase 3 was detectable in the early phase of acute liver
injury. We cannot exclude the possibility that the
observed increase in mouse SB3 may be contributed by
other cell types, rather than the progenitors, since acti-
vated B lymphocytes have been also reported to express
SB3 [43]. Transcription analysis confirmed the presence
of SB3-homologous only in the liver of injured mice
and sequence analysis proved its belonging to mouseSerpinb3b. This serpin, one of the four isoforms of the
Serpinb3 mouse gene, is the counterpart of the human
SB3 and shares 73% aminoacid similarity. Both are dual
cross-class inhibitors of cysteine and serine proteinases
[16,44], supporting the hypothesis that they retained
these activities from an ancestral SCCA-like gene.
SB3 is a multifunctional protein that, beyond its anti-
protease activity, makes cells more resistant to several
killing mechanisms by inhibition of apoptosis [12]. The
results obtained in LPS/D-GalN treated mice confirmed
that overexpression of Serpinb3b in the liver was associ-
ated with a marked decrease of the activated caspase 3,
which represents a well-defined hallmark of apoptosis.
SB3 has been detected recently in hepatoblastoma, the
embryonal tumor of the liver, and a direct correlation was
observed between its gene expression, the up-regulation
of Myc oncogene and tumor extension [6]. In addition,
in vitro experiments documented the primary involvement
of SB3 in the up-regulation of Myc transcription [7]. This
serpin has been also shown to be able to increase TGF-β
expression in hepatic cell lines and in primary hepato-
cytes [8]. Chronic stimulation of hepatic progenitor
cells by TGF-β has been shown recently to induce their
transformation into cancer stem cell/tumor-initiating
cells [45], suggesting the involvement of triggering auto-
crine and paracrine mechanisms in hepatocarcinogen-
esis. These observations, together with the fact that SB3
was found to promote epithelial to mesenchymal transi-
tion and to increase cell proliferation and invasiveness
[14], may suggest a carcinogenic potential of hepatic
progenitor cells expressing this serpin.
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SB3 was detectable in human progenitor cells compartment
within the same ductular structures that express stem/pro-
genitor cell markers, such as CK-7, CK-19, EpCAM and
CD90. In addition, SB3 was detected in EpCAM+ cell frac-
tions sorted from human foetal and adult livers. The mouse
homologous, Serpinb3b, was induced in a mouse model of
liver stem/progenitor cell activation.
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